Cargando…

Association between circulating exhausted CD4(+) T cells with poor meningococcal C conjugate vaccine antibody response in HIV-infected children and adolescents

OBJECTIVES: To investigate the expression levels of surface markers of activation (CD38 and HLA-DR), inhibition (PD-1, TIGIT and CD57) and co-stimulation (CD28 and CD127) on CD4(+) T cells of children/adolescents with vertical HIV infection (HI patients) and HIV-uninfected (HU) controls vaccinated w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva, Giselle P., Pereira-Manfro, Wania F., Costa, Priscilla R., Costa, Dayane A., Ferreira, Bianca, Barreto, Daniela M., Frota, Ana Cristina C., Hofer, Cristina B., Figueredo, Carlos M., Coelho, Barbara, Kallas, Esper G., Milagres, Lucimar G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculdade de Medicina / USP 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449930/ https://www.ncbi.nlm.nih.gov/pubmed/34614112 http://dx.doi.org/10.6061/clinics/2021/e2902

Ejemplares similares

Baseline Circulating Activated TFH and Tissue-Like Exhausted B Cells Negatively Correlate With Meningococcal C Conjugate Vaccine Induced Antibodies in HIV-Infected Individuals
por: Milagres, Lucimar, et al.
Publicado: (2018)

Expression of TIGIT, PD-1 and HLA-DR/CD38 markers on CD8-T cells of children and adolescents infected with HIV and uninfected controls
por: Pereira-Manfro, Wânia Ferraz, et al.
Publicado: (2023)

Subsets of Memory CD4(+) T Cell and Bactericidal Antibody Response to Neisseria meningitidis Serogroup C after Immunization of HIV-Infected Children and Adolescents
por: Milagres, Lucimar G., et al.
Publicado: (2014)

Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease
por: Kimmel, Sanford R
Publicado: (2008)

Inversion of the Vδ1 to Vδ2 γδ T cell ratio in CVID is not restored by IVIg and is associated with immune activation and exhaustion
por: Paquin-Proulx, Dominic, et al.
Publicado: (2016)

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) vs. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study
por: van der Vliet, D., et al.
Publicado: (2021)

Meningococcal conjugate vaccines: optimizing global impact
por: Terranella, Andrew, et al.
Publicado: (2011)

Factors contributing to the immunogenicity of meningococcal conjugate vaccines
por: Bröker, Michael, et al.
Publicado: (2016)

Conjugate Meningococcal Vaccines Development: GSK Biologicals Experience
por: Miller, Jacqueline M., et al.
Publicado: (2011)

Technical Development of a New Meningococcal Conjugate Vaccine
por: Frasch, Carl E., et al.
Publicado: (2015)

Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil
por: Nunes, Amélia Maria Pithon Borges, et al.
Publicado: (2016)

Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil
por: Tauil, Márcia de Cantuária, et al.
Publicado: (2014)

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
por: Hedari, Carine P, et al.
Publicado: (2014)

A Mouse Immunogenicity Model for the Evaluation of Meningococcal Conjugate Vaccines
por: Arunachalam, Arun B., et al.
Publicado: (2022)

The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine
Publicado: (2015)

Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011–2017
por: Fernandez, Katya, et al.
Publicado: (2019)

Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013
por: Gamougam, Kadidja, et al.
Publicado: (2015)

Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial
por: Knuf, Markus, et al.
Publicado: (2022)

Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines
por: Alderson, Mark R, et al.
Publicado: (2019)

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
por: Sow, Samba O., et al.
Publicado: (2023)

Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity
por: Wing, James B., et al.
Publicado: (2012)

Meningococcal Disease in US Military Personnel before and After Adoption of Conjugate Vaccine
por: Broderick, Michael P., et al.
Publicado: (2015)

Meningococcal Disease in US Military Personnel before and after Adoption of Conjugate Vaccine
por: Decker, Michael D.
Publicado: (2016)

2461. Safety of Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid-Conjugate Vaccine in Adolescents
por: Myers, Tanya, et al.
Publicado: (2018)

Meningococcal ACWYX conjugate vaccine in 2–29 year-olds in Mali and Gambia
por: Haidara, Fadima Cheick, et al.
Publicado: (2023)

Molecular insights into meningococcal carriage isolates from Burkina Faso 7 years after introduction of a serogroup A meningococcal conjugate vaccine
por: Topaz, Nadav, et al.
Publicado: (2020)

Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programs
por: Tin Tin Htar, Myint, et al.
Publicado: (2020)

Control of meningococcal meningitis with meningococcal vaccines.
por: Artenstein, M. S.
Publicado: (1975)

ROLE OF MENINGOCOCCAL ENDOTOXIN IN MENINGOCOCCAL PURPURA
por: Davis, Charles E., et al.
Publicado: (1974)

Safety and immunogenicity of two doses of quadrivalent meningococcal conjugate vaccine or one dose of meningococcal group C conjugate vaccine, both administered concomitantly with routine immunization to 12- to 18-month-old children
por: Noya, Francisco, et al.
Publicado: (2014)

Development of a New Solid-Phase Extraction Base Method for Free Saccharide Content Estimation of Meningococcal Conjugate Vaccines
por: De Ricco, Riccardo, et al.
Publicado: (2022)

Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study
por: Daugla, DM, et al.
Publicado: (2013)

Primary Meningococcal Polyarthritis in an Adult Woman
por: Sarinho, José Celso Giordan Cavalcanti, et al.
Publicado: (2015)

Editorial: T Cell Exhaustion
por: Bonorino, Cristina, et al.
Publicado: (2020)

Correction: Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity
por: Wing, James B., et al.
Publicado: (2012)

Effectiveness of Meningococcal C Conjugate Vaccine in Salvador, Brazil: A Case-Control Study
por: Cardoso, Cristiane Wanderley, et al.
Publicado: (2015)

Safety Monitoring in Group A Meningococcal Conjugate Vaccine Trials: Description, Challenges, and Lessons
por: Enwere, Godwin C., et al.
Publicado: (2015)

Risk Assessment and Meningococcal A Conjugate Vaccine Introduction in Africa: The District Prioritization Tool
por: Cibrelus, Laurence, et al.
Publicado: (2015)

Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine
por: Watle, Sara Viksmoen, et al.
Publicado: (2021)

Preclinical development of the quadrivalent meningococcal (ACYW) tetanus toxoid conjugate vaccine, MenQuadfi®
por: Kensinger, Richard, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bin5g1k9j6bnobs956lq2ima2a